Related Experiment Video
Updated: May 15, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Decoding Pathogenic Mutational Landscapes in Alzheimer's Disease Through Integrated Transcriptomics
Wan Ma1, Fenfang Zhou1, Huaying Cai2
1Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China, zju.edu.cn.
None:
Alzheimer's disease (AD) is increasingly understood as a disorder driven not only by amyloid and tau pathology but also fundamentally shaped by underlying genetic mutations. By integrating multiple AD gene expression datasets with machine learning approaches-including random forest, XGBoost, LASSO, and SVM-we identified 172 differentially expressed genes, with TUBB2A, RTN4, and YWHAZ emerging as top mutation-associated hub genes. Critically, TUBB2A not only exhibited strong diagnostic potential (AUC = 0.822) but also harbored somatic mutations in our patient cohort, directly linking mutational events to disease manifestation. Unsupervised clustering revealed two distinct AD subtypes: one marked by widespread early gene overexpression and another (Cluster 2) dominated by endoplasmic reticulum stress-likely reflecting divergent mutational landscapes. Pseudotemporal trajectory analysis demonstrated a continuous progression from normal samples to Cluster 2, suggesting that a pivotal mutational event may initiate this transition and accelerate disease progression. These findings underscore the central role of somatic and germline mutations-particularly in TUBB2A-in AD pathogenesis. Our study strongly supports a paradigm shift toward mutation-centric biomarker development and advocates for SNP-based strategies to enable early diagnosis and personalized therapeutic interventions tailored to individual mutational profiles.
More Related Videos
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
04:22Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Pharmacogenomics: Identification of New Drug Targets